Results per Page:
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
The exclusion of immunocompromised patients in clinical trials and how we can do better
From Drs. Michael Boeckh, Joshua Hill, Steven Pergam and Larry Corey, Hematologic Malignancies and Cancer Immunology Programs of the Cancer Consortium
A coordinated care approach rapidly gets COVID-19 therapy into the hands of high-risk cancer patients
From Drs. Eduardo Sanchez, Steven Pergam, and Catherine Liu, ,Fred Hutch Vaccine and Infectious Diseases Division and Cancer Consortium Hematologic Program
The Beam: New breast cancer specialist Dr. Kylie Kang; new role for Dr. Stephanie Schaub and Thanksgiving nutritional advice
Meet our newest doctor, learn about a key provider's new role and some recipes to try for Thanksgiving
Year in Pictures: 2022
A look back at the year through compelling images
COVID-19 complacency: ‘A hard shift for the immunocompromised’
Even with vaccines and antivirals, cancer patients and many others are still vulnerable to infection; some safety tips for this evolving pandemic
Cancer, COVID-19 and proceeding with caution
Patients in treatment and those with compromised or suppressed immune systems eye the future — and pandemic’s wane — warily
Hutch researchers discover neutralizing antibodies to parainfluenza
New hope for transplant patients vulnerable to this common respiratory virus
Experts discuss navigating cancer and cancer research during the pandemic
Hutch panelists offer their insights on how COVID-19 has impacted patients as well as their efforts to develop cancer treatments
Patients navigate cancer during COVID-19 pandemic
Scary waiting rooms, delayed scans and ‘virtual’ care: patients and providers try to dodge the collateral damage of coronavirus
What happens when cancer patients get COVID-19?
Large new observational study of nearly 1,000 patients breaks down who’s most at risk with coronavirus, highlights need for additional care
Lessons from cancer patients in the time of coronavirus
For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude and dancing help.
Coronavirus: what cancer patients need to know
Advice for cancer patients, survivors and caregivers on who’s most at risk for COVID-19 and what you can do to stay healthy
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Why now is the time to get your flu shot
Protecting yourself also helps those around you, especially cancer patients vulnerable to influenza